E-LIB Suche - Ergebnisse für: van Leth, F

1

Predictive performance of interferon-gamma release assays a..:

Hamada, Y ; Gupta, RK ; Quartagno, M...
https://discovery.ucl.ac.uk/id/eprint/10163220/1/PIIS2589537022005442.pdf. , 2023

Link: https://discovery.ucl.ac..

2

Estimating the contribution of subclinical tuberculosis dis..:

Emery, J.C ; Dodd, P.J ; Banu, S...
https://eprints.whiterose.ac.uk/207068/1/elife-82469-v1.pdf. , 2023

Link: https://eprints.whiteros..

3

Rifapentine access in Europe: growing concerns over key tub..:

Guglielmetti, L ; Günther, G ; Leu, C...
Eur Respir J. 2022 May 19;59(5):2200388. doi:10.1183/13993003.00388-2022. Print 2022 May.. , 2022

Link: https://hdl.handle.net/1..

4

The use of ultrasensitive quantitative-PCR to assess the im..:

Phommasone, K ; Van Leth, F ; Imwong, M...
doi:10.1186/s12936-019-3091-5. , 2020

Link: https://doi.org/10.1186/..

5

"A false sense of confidence" The perceived role of inflamm..:

Kuil, S. D ; Schneeberger, C ; van Leth, F..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643302/. , 2020

Link: http://www.ncbi.nlm.nih...

6

Discovery and validation of a personalized risk predictor f..:

Gupta, RK ; Calderwood, CJ ; Yavlinsky, A...
https://discovery.ucl.ac.uk/id/eprint/10113789/9/Lipman_PERISKOPE-TB_main_R3_submitted_clean_2020-08-26.pdf. , 2020

Link: https://discovery.ucl.ac..

7

Sensitivity of C-Reactive Protein and Procalcitonin Measure..:

Kuil, S D ; Hidad, S ; Fischer, J C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664473/. , 2020

Link: http://www.ncbi.nlm.nih...

8

Mass drug administrations with dihydroartemisinin-piperaqui..:

Phommasone, K ; Van Leth, F ; Peto, TJ...
doi:10.1371/journal.pone.0228190. , 2020

Link: https://doi.org/10.1371/..

9

Management of patients with multidrug-resistant tuberculosi:

Lange, C ; Aarnoutse, R. E ; Alffenaar, J. W. C...
https://research.rug.nl/en/publications/5b34d11c-a322-4f2a-9645-e3c0f405dd83. , 2019

Link: https://hdl.handle.net/1..

10

Management of patients with multidrug-resistant tuberculosi:

Lange, C ; Aarnoutse, RE ; Alffenaar, JWC...
The International Journal of Tuberculosis and Lung Disease, Volume 23, Number 6, 1 June 2019, pp. 645-662(18). , 2019

Link: https://hdl.handle.net/1..

11

Bridging the TB data gap: in silico extraction of rifampici..:

Ng, K.C.S ; Ngabonziza, J.C.S ; Lempens, P...
https://doi.org/10.7717/peerj.7564. , 2019

Link: http://hdl.handle.net/10..

12

The Tuberculosis Network European Trials group (TBnet) ERS ..:

van Leth, F ; Brinkmann, F ; Cirillo, DM...
Eur Respir J. 2019 Jan 3;53(1):1802089. doi:10.1183/13993003.02089-2018. Print 2019 Jan.. , 2019

Link: https://hdl.handle.net/1..

13

Treatment responses in multidrug-resistant tuberculosis in ..:

Heyckendorf, J ; van Leth, F ; Avsar, K...
https://researchonline.lshtm.ac.uk/id/eprint/4652419/1/Heyckendorf%20et%20al%20IJTLD%20R1%20MARKED%2024112017%20for%20archiving.pdf. , 2018

Link: https://researchonline.l..

14

Clinical Management of Multidrug-Resistant Tuberculosis in ..:

Guenther, G ; Leth, F ; Alexandru, S...
Am J Respir Crit Care Med. 2018 Aug 1;198(3):379-386. doi:10.1164/rccm.201710-2141OC.. , 2018

Link: https://hdl.handle.net/1..

15

Treatment outcomes of MDR-TB and HIV co-infection in Europe:

Magis-Escura, C ; Günther, G ; Lange, C...
Eur Respir J, vol. 49(6). , 2017

Link: http://hdl.handle.net/10..